AKLI

Akili (AKLI)

Akili Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:AKLI

1 2 3 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/19	05 : 09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AKLI	Akili Inc
2024/06/19	05 : 01	Business Wire	Akili Announces FDA Authorization of EndeavorOTC, the First FDA Clearance of a Digital Treatment for Adults with ADHD Through a Video Game	NASDAQ:AKLI	Akili Inc
2024/06/04	06 : 21	Edgar (US Regulatory)	Form SC TO-T - Tender offer statement by Third Party	NASDAQ:AKLI	Akili Inc
2024/05/30	06 : 32	Edgar (US Regulatory)	Form SC TO-C - Written communication relating to an issuer or third party	NASDAQ:AKLI	Akili Inc
2024/05/30	05 : 05	Edgar (US Regulatory)	Form SC14D9C - Written communication relating to third party tender offer	NASDAQ:AKLI	Akili Inc
2024/05/29	22 : 16	Edgar (US Regulatory)	Form SC14D9C - Written communication relating to third party tender offer	NASDAQ:AKLI	Akili Inc
2024/05/29	22 : 14	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AKLI	Akili Inc
2024/05/29	21 : 00	Business Wire	Virtual Therapeutics, Akili Interactive Enter Into Definitive Merger Agreement to Establish Leading Digital Health Company	NASDAQ:AKLI	Akili Inc
2024/05/15	05 : 16	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:AKLI	Akili Inc
2024/05/15	05 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AKLI	Akili Inc
2024/05/15	05 : 01	Business Wire	Akili Reports First Quarter 2024 Financial Results and Provides Business Update	NASDAQ:AKLI	Akili Inc
2024/05/07	06 : 32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AKLI	Akili Inc
2024/04/30	21 : 00	Business Wire	Akili Announces Amended Agreement with Shionogi, Shift in Corporate Strategy and Release Date for First Quarter 2024 Financial Results	NASDAQ:AKLI	Akili Inc
2024/03/07	06 : 28	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:AKLI	Akili Inc
2024/03/07	06 : 11	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:AKLI	Akili Inc
2024/03/07	06 : 07	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:AKLI	Akili Inc
2024/03/01	06 : 01	Business Wire	Akili Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	NASDAQ:AKLI	Akili Inc
2024/02/27	16 : 00	Business Wire	PureTech Founded Entity Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx ® for Pediatric ADHD Patients in Japan	NASDAQ:AKLI	Akili Inc
2024/02/26	23 : 04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AKLI	Akili Inc
2024/02/26	22 : 47	Business Wire	Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx® for Pediatric ADHD Patients in Japan	NASDAQ:AKLI	Akili Inc
2024/02/24	07 : 43	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AKLI	Akili Inc
2024/02/24	07 : 28	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:AKLI	Akili Inc
2024/02/23	21 : 57	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:AKLI	Akili Inc
2024/02/22	06 : 11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AKLI	Akili Inc
2024/02/22	06 : 05	Business Wire	Akili Announces Release Date for Fourth Quarter and Full Year 2023 Financial Results, Provides Investor Communications and Board and Corporate Governance Updates	NASDAQ:AKLI	Akili Inc
2024/01/06	06 : 17	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AKLI	Akili Inc
2023/12/21	06 : 58	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AKLI	Akili Inc
2023/12/18	22 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AKLI	Akili Inc
2023/12/18	22 : 00	Business Wire	EndeavorRxⓇ, World’s First and Only Prescription Video Game Treatment, Secures FDA Label Expansion for Pediatric ADHD Patients Aged 13-17	NASDAQ:AKLI	Akili Inc
2023/12/09	07 : 32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AKLI	Akili Inc